Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model

Aims. The priority of Chinese herbal medicines (CHMs) plus conventional treatment over conventional treatment alone for acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI) was documented in the 5C trial (chictr.org number: ChiCTR-TRC-07000021). The study was designed to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shao-Li, Wang, Cheng-Long, Wang, Pei-Li, Xu, Hao, Chen, Ke-Ji, Shi, Da-Zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606398/
https://www.ncbi.nlm.nih.gov/pubmed/26495019
http://dx.doi.org/10.1155/2015/639267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606398/
https://www.ncbi.nlm.nih.gov/pubmed/26495019
http://dx.doi.org/10.1155/2015/639267

Ejemplares similares